Lung Injury Risk in Traumatic Brain Injury Managed With Optimal Cerebral Perfusion Pressure Guided-Therapy
, , , , und
08. Mai 2023
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 08. Mai 2023
Seitenbereich: 97 - 105
Eingereicht: 11. Aug. 2022
Akzeptiert: 31. Jan. 2023
DOI: https://doi.org/10.2478/jccm-2023-0009
Schlüsselwörter
© 2023 Celeste Dias et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig. 1.

Fig. 2.

Fig. 3.

Demographic, Monitoring, Management and Outcome data of patients with severe acute Traumatic Brain Injury_
Variables | Mean±sd /Median (IQR) | |
---|---|---|
Number of Patients | Total | 92 |
Multiple Trauma | 45 (49%) | |
Thoracic Trauma | 19 (21%) | |
Age (Years) | 53 ± 21 | |
Gender | Male | 79 (86%) |
Female | 13 (14%) | |
GCS at admission | 7 (IQR 5) | |
APACHE II | 19 ± 6 | |
Apache II mortality (%) | 33 ± 17 | |
CT Marshall Classification | 3 (IQR 2) | |
FiO2 | 0.5 ± 0.13 | |
PFratio | 305 ± 88 | |
PaO2(mmHg) | 146.5 ± 28.5 | |
PaCO2(mmHg) | 38.1 ± 3.7 | |
SaO2(%) | 98.6 ± 0.74 | |
RR (cycles/min) | 17 ± 4 | |
MV (L/min) | 9.45 ± 2.18 | |
PEEP (cmH20) | 6,2 ± 1,3 | |
Ppl (cmH20) | 19.7 ± 4.8 | |
DP=Ppl-PEEP (cmH20) | 15.9 ± 3.5 | |
Shunt fraction (Qs/Qt) (%) | 16.3±6.7 | |
Compliance | 43 ± 13.8 | |
Fluid Balance (ml/d) | 171 ± 564 | |
Therapy Intensity Level (TIL) | 2 (IQR 1) | |
HR (bpm) | 71.9 ± 10.5 | |
ABP (mmHg) | 96.7 ± 7.0 | |
ICP (mmHg) | 11.2 ± 5.8 | |
CPP(mmHg) | 85.9 ± 7.4 | |
PRx | 0.03 ± 0.19 | |
CPPopt (mmHg) | 88.7 ± 8.5 | |
CPP-CPPopt (mmHg) | −2.8 ± 10.2 | |
LOS ICU (days) | 22 ± 26 | |
LOS Hosp (days) | 48 ± 48 | |
Mortality | 14 (15.2%) | |
GOS at 3 months | 3 (IQR 2) |
Estimates from the final mixed-effects regression models for PFratio, CPP-CPPopt and Driving Pressure across time (10 days), adjusted for other variables of interest_
Variables | FIXED EFFECTS | RANDOM EFFECT | ||
---|---|---|---|---|
Coefficient | St Error | p-value | St deviation | |
Intercept | 436.42 | 17.63 | <0.001 | 59.25 |
Time (days) | −27.12 | 4.56 | <0.001 | |
Days2 | 2.175 | 0.48 | <0.001 | |
Female | 99.28 | 23.39 | <0.001 | |
PRx | −49.99 | 15.68 | 0.002 | |
Ppl-Peep | −5.34 | 0.97 | <0.001 | |
Intercept | −2.37 | 1.58 | 0.133 | 2.95 |
Dead | −0.79 | 1.72 | 0.647 | |
Time (days) | −0.56 | 0.28 | 0.048 | |
Time*Dead | 1.10 | 0.31 | <0.001 | |
Intercept | 14.76 | 1.10 | <0.001 | 2.85 |
Dead | −0.43 | 1.20 | 0.718 | |
Time (days) | 0.68 | 0.15 | <0.001 | |
Time*Dead | −0.34 | 0.17 | 0.041 |